Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/05/3094322/0/en/ViGeneron-Rebrands-as-VeonGen-Therapeutics-and-Announces-FDA-Rare-Pediatric-Disease-Designation-and-Clinical-Progress-for-Lead-Gene-Therapy-VG801-in-Stargardt-Disease.html
08 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/08/3006207/0/en/ViGeneron-Announces-FDA-Rare-Pediatric-Disease-Designation-for-VG901-and-DSMB-Approval-to-Advance-Dose-Escalation-in-Phase-1b-Retinitis-Pigmentosa-Trial.html
18 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/18/2999005/0/en/ViGeneron-Announces-FDA-Clearance-of-IND-for-Novel-mRNA-Trans-Splicing-Gene-Therapy-VG801-to-Treat-Stargardt-Disease-and-Other-ABCA4-Linked-Retinal-Dystrophies.html
10 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/10/2860550/0/en/ViGeneron-Announces-First-Patient-Dosed-in-Phase-1b-Clinical-Trial-of-VG901-for-the-Intravitreal-Treatment-of-Retinitis-Pigmentosa.html
25 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/25/2766475/0/en/Nature-Communications-publication-reveals-highly-efficient-AAV-delivery-of-large-genes-using-ViGeneron-s-REVeRT-technology.html
29 Apr 2022
// BIOSPECTRUMASIA
https://www.biospectrumasia.com/news/26/20202/vigeneron-daiichi-sankyo-to-develop-novel-gene-therapy-for-prevalent-eye-diseases.html
ABOUT THIS PAGE